Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Beuther to Disease Progression

This is a "connection" page, showing publications David Beuther has written about Disease Progression.

 
Connection Strength
 
 
 
0.261
 
  1. Murphy KR, Beuther DA, Chipps BE, Wise RA, McCann WA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Zeiger RS. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability. J Allergy Clin Immunol Pract. 2024 Aug; 12(8):2092-2101.e4.
    View in: PubMed
    Score: 0.120
  2. Beuther DA, Murphy KR, Zeiger RS, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Chipps B. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. J Allergy Clin Immunol Pract. 2022 Dec; 10(12):3204-3212.e2.
    View in: PubMed
    Score: 0.107
  3. McCann WA, Chipps BE, Beuther DA, Zeiger RS, Wise RA, George M, Gilbert I, Eudicone JM, Gandhi HN, Cutts K, Harding G, Murphy KR, Reibman J. Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities. Ann Allergy Asthma Immunol. 2026 06; 136(6):658-664.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)